The market for biosensors is anticipated to grow at a CAGR of 8.5% during the forecast period 2022 to 2030. The need for biosensors is developing as a result of a wide variety of medical applications, an increasing number of people living with diabetes, a high demand for miniature diagnostic devices, and rapid technological advancements. It is essential for a favorable disease prognosis and patient survival that the disease is diagnosed correctly and at an early stage. In recent years, there has been a meteoric rise in the demand for one-time-use devices that are disposable, user-friendly, and have low production costs and short reaction times. The capacity of these devices to meet these criteria through an interdisciplinary combination of approaches from fields such as chemistry and nanotechnology, as well as medical research, has contributed to their rapid advancement in the realm of medicine.
During the time under consideration, it is anticipated that the revenue generated by the food toxicity segment will have a quick growth rate. Concerns about food toxicity and risks to human health are growing and have become more concerning globally as a result of an increase in the number of establishments that provide mass catering, an increase in the number of consumers who eat out or order in, and changing habits regarding food consumption. The process of determining whether or not a product is poisonous is a significant challenge in this age of rising globalization of food supply chains; as a result, numerous nations are adopting increasingly strict regulations in this area. Controlling the quality of food is also extremely important in the food industry, both for the protection of consumers and their safety. As a result, testing for the presence of pollutants in food is becoming increasingly dynamic across the food industries and is considerably contributing to the expansion of market revenue.
In 2021, the point-of-care testing segment was the dominant player in the market and accounted for around 50% of the total revenue. Technological advancements in the creation of breakthrough products, such as biosensors ultrasensitive printable for point-of-care applications that help monitor or sense organic fluids like blood, urine, saliva, and perspiration, are among the key rendering drivers attributed to the growth of biosensors in the PoC testing market over the forecast period. This growth is expected to continue over the course of the next few years. The users of these systems have access to results that are both quick and accurate, which enables earlier diagnosis and more expedient treatment. Continuous research and development are leading to the creation of next-generation point-of-care biosensors. These biosensors include label-free optical techniques such as surface plasmon resonance, localized surface plasmon resonance, and improved spectroscopy techniques. It is anticipated that this will boost the demand for biosensors in point-of-care diagnostics over the course of the forecast period.
The market for biosensors in APAC is likely to exhibit the highest growth rate from 2022 to 2030. The expansion of the market in APAC is being driven primarily by several factors, the most important of which are the region's vast population base and the rising prevalence of a variety of lifestyle-related disorders. Both in terms of the removal of items from the National Negative List and the addition of items to the National Encouraged List, the healthcare industry in China has been steadily opening up to the participation of foreign investors. This is true both in terms of the removal of items from the National Negative List and the addition of items to the National Encouraged List. The 2019 National Encouraged List was updated to include a number of newly added raw materials 2019. These raw materials will be used in the production of vaccines and medical facilities. This suggests that China is now encouraging investments across the healthcare industry and opening the door for opportunities for international companies to receive preferential regulations and tax rates. It is anticipated that such policies will generate a number of opportunities for the biosensors market in the APAC region.
During the period covered by the forecast, the market is anticipated to expand at a rate that is highest in both the Middle East and Africa. Some of the primary factors that are driving the market in the Middle East and Africa include the presence of significant unmet medical requirements for target diseases such as diabetes, cancer, and other infectious diseases; continuously improving healthcare expenditure in the region; and increasing patient awareness. A rise in demand for point-of-care, home healthcare, and other healthcare businesses that cater to the adult population, as well as measures taken by the government to reduce the length of patients' stays in hospitals by developing outpatient care models, are likely to fuel the expansion of the market over the course of the forecast period.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Nanotechnology-Based Biosensors to Boost the Market Growth
Biosensors that are powered by nanotechnology are fabricated from nanomaterials and have diameters that range from 1 to 100 nanometers. When it comes to sensing the mechanism of biosensing technology, these biosensors are an essential component. The development of nanoelectromechanical systems can be attributed to the integration of devices made of nanomaterials with electrical systems. Several different nanomaterials have been investigated for their potential electrical and mechanical properties as a means of enhancing the biological signaling and transduction system. This improvement requires the transformation of one kind of energy into another. Nanotubes, nanowires, nanorods, nanoparticles, and thin films comprised of crystalline matter are some examples of the types of materials that fall within this category and are used extensively. Applications for these sensors include amperometric devices for the enzymatic detection of glucose, the use of quantum dots as fluorescent agents for the detection of binding, and bio-conjugated nanomaterials for the detection of biomolecular compounds.High Price of Biosensors in a Cause of Concern
In recent years, the commercialization of biosensor technology has moved at a glacially slow pace. This is mostly attributable to the high price of biosensors as well as the demand coming solely from the healthcare business. Due to limited research and development and favorable results, industry players face a barrier when it comes to the commercialization of biosensors for use in nonmedical applications such as the military, biodefense, fermentation control, and environmental monitoring. In addition, the commercialization of the biosensors market is moving at a snail's pace. This is mostly attributable to the price sensitivity of end users, as well as acceptance from end users and concerns regarding the quality, authenticity, and dependability of the goods.Wearable Technology to Present Significant Opportunities
Wearable biosensors are finding an expanding number of applications for the continuous monitoring of vital signs of patients, premature newborns, children, athletes or fitness buffs, and persons who live in rural places that are a significant distance from medical and health care services. Patients may be able to avoid hospitalization or leave the facility earlier thanks to remote monitoring made possible by biosensors that are both wearable and networked. Wearable biosensors have the potential to reduce the workload of medical staff and liberate hospital space for the provision of care that is more responsive to patients' needs by enabling telemedicine, which is the monitoring and transmission of physiological data from locations outside of the hospital. The use of smart textiles that include sensors in the fabric can make the monitoring of vital signs much easier and more convenient. When combined with conformal, printed electronics, biosensor patches or tattoos can significantly improve a physician's ability to collect data on a patient over an extended period of time. These sensors are compatible with the growing concept of the quantified self, which entails keeping track of one's biological data in order to improve one's health. In addition, reusable patches can be used to analyze essential biomarkers in sweat, including salt, potassium, and glucose. These biomarkers can be found in a variety of substances.Lengthy Processes of Certification and Approvals to Remain a Significant Challenge
Despite the high demand for biosensors to be used in medical applications, manufacturers are running into a number of regulatory roadblocks as a result of the multi-layered regulations that have been mandated by the FDA as well as the laboratory regulations that have been implemented as a result of the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (for the premarket approval of POC testing kits). The Food and Drug Administration (FDA) requires makers of each new point-of-care (POC) device in the United States to submit performance data before the device may be approved. Using these data, healthcare practitioners and patients should be able to demonstrate that they can use devices to generate findings that are comparable to clinical laboratory testing.Embedded Device Segment Dominated the Market Revenues in 2021
The market for biosensors is broken down into many types, and embedded devices hold the majority of those market shares. These devices have a wide range of applications and are utilised often in a variety of contexts, including point-of-care settings, in-home diagnostics, food, and beverage production, research labs, environmental monitoring, and biodefense. There has been a significant paradigm shift in the linked healthcare applications that are available as a result of the proliferation of devices that are connected to the Internet of Things (IoT). The Internet of Things offers real-time alerting, tracking, and monitoring, which enables more hands-on treatments, increased accuracy, and appropriate intervention by doctors, leading to enhanced overall patient care. To compensate for the scarcity of medical professionals in rural areas, some healthcare facilities have begun implementing embedded solutions for medical devices that are connected with the internet of things technology. These medical devices that are enabled by the internet of things help diagnose disorders in patients and conduct various tests so that accurate and reliable therapy may be provided to patients located in remote areas. As a result, the growing popularity of embedded devices will be the primary factor propelling the expansion of the biosensors market.Medical Segment to Dominate the Revenue While Food Toxicity Segment to Promise Growth
In 2021, the medical sector held a dominant position in the market, accounting for the greatest revenue share at approximately 67% of the total. In the medical industry, biosensors find applications in the domains of cholesterol testing, blood glucose monitoring, blood gas analyzers, pregnancy testing, drug development, and infectious disease diagnosis. It is widely recognized as an important tool for diagnosing and keeping track of a broad spectrum of medical conditions, including diabetes and cancer, amongst others. The growing number of people who have diabetes is a significant element that is contributing to the expansion of the market sector. In order to assist patients with diabetes in keeping their blood glucose levels within normal ranges, a number of technologically advanced biosensors for glucose have been developed.During the time under consideration, it is anticipated that the revenue generated by the food toxicity segment will have a quick growth rate. Concerns about food toxicity and risks to human health are growing and have become more concerning globally as a result of an increase in the number of establishments that provide mass catering, an increase in the number of consumers who eat out or order in, and changing habits regarding food consumption. The process of determining whether or not a product is poisonous is a significant challenge in this age of rising globalization of food supply chains; as a result, numerous nations are adopting increasingly strict regulations in this area. Controlling the quality of food is also extremely important in the food industry, both for the protection of consumers and their safety. As a result, testing for the presence of pollutants in food is becoming increasingly dynamic across the food industries and is considerably contributing to the expansion of market revenue.
Wearable Biosensors to Grow at the Fastest Pace During the Forecast Period
Because of its potential to revolutionize the concepts of traditional medical diagnostics and continuous health monitoring, wearable biosensors have garnered a significant amount of attention in recent years. The applications of wearable biosensors aim to convert centralized healthcare systems centered in hospitals to home-based personal medicine, as well as minimize the cost of healthcare and the amount of time needed for diagnosis. At this point in time, it is plain to observe that wearable biosensors are ushering in a new era of innovation inside society. The ease with which they can be used and improved effectiveness can provide a new level of insight into the current state of a patient's health. The availability of data in real-time enables better clinical judgments, which in turn leads to improved health outcomes and more effective utilization of health services. Additionally, wearable biosensors are currently being integrated with innovative features such as sensors that measure glucose levels every minute and provide real-time updates and alerts. This helps to monitor critical events such as hypoglycemia or hyperglycemia, which are both potentially life-threatening conditions.Electrochemical Technology Category Dominated the Revenue Share In 2021
In 2021, the electrochemical sector was the market leader and secured the biggest revenue share, amounting to around 70% of total sales. This is due to the widespread application of its monitoring and analytical capabilities across all biochemical and biological processes. Electrochemical biosensors provide a number of benefits, some of which include low detection limits, a large linear response range, high stability, and repeatability. The electrochemical detection method has more advantages than piezoelectric, thermal, and optical detection, which has led to greater market penetration and consumption of the electrochemical detection method. The benefits include, but are not limited to, robustness, compatibility with new microfabrication methods, ease of operation, low cost, disability, independence from sample turbidity, and low power requirements.Optical Sensors to Grow with Highest CAGR
The optical sector is anticipated to experience the greatest rate of expansion throughout the forecast period of 2022 to 2030. Because of their extensive analytical coverage, it is anticipated that there will be a growth in demand for optical biosensors in the analysis over the duration of the projection period. Optical biosensors make it possible to conduct studies on topics such as receptor-cell interactions, fermentation monitoring, structural study, as well as concentration, kinetic, and equilibrium assessments. As a consequence of the aforementioned considerations, it is anticipated that the market for optical biosensors will expand. Compared to conventional methods of analysis, optical biosensors offer a number of benefits, the most notable of which are the removal of the prerequisite for extensive sample preparation and the availability of the option to select a particular biological sensing element.Among the End Users Home Diagnostics to Grow the Fastest
During the forecast period, the market for applications related to home diagnostics is anticipated to expand at the fastest rate. It is possible to credit the expansion of the market to increasing innovations in the healthcare sector, a high rate of acceptance of new diagnostic procedures, and the convenience of utilizing home-based medical devices. As a result of the emergence of the new coronavirus, there has been an upsurge in the demand for home diagnostics. As a result, firms competing in the market for home diagnostics are extending their capacity for production. Additionally, there is a rise in demand across the wearable devices segment, and as lifestyle disorders grow more common, there is a significant amount of untapped potential in the biosensors market inside the home diagnostics segment.In 2021, the point-of-care testing segment was the dominant player in the market and accounted for around 50% of the total revenue. Technological advancements in the creation of breakthrough products, such as biosensors ultrasensitive printable for point-of-care applications that help monitor or sense organic fluids like blood, urine, saliva, and perspiration, are among the key rendering drivers attributed to the growth of biosensors in the PoC testing market over the forecast period. This growth is expected to continue over the course of the next few years. The users of these systems have access to results that are both quick and accurate, which enables earlier diagnosis and more expedient treatment. Continuous research and development are leading to the creation of next-generation point-of-care biosensors. These biosensors include label-free optical techniques such as surface plasmon resonance, localized surface plasmon resonance, and improved spectroscopy techniques. It is anticipated that this will boost the demand for biosensors in point-of-care diagnostics over the course of the forecast period.
North America Dominated the Global Market in 2021
Because of the existence of key companies and the rising incidence rate of targeted diseases in the region, North America owned the greatest revenue share in 2021, which was approximately 40%. It is anticipated that technological advancements, such as the introduction of miniaturized diagnostic equipment that provides increased market penetration of Electronic Medical Records (EMR), as well as precise and speedy findings, will fuel the expansion of the market over the course of the foreseeable future. In addition, the United States has legislation known as the Clean Air Act, the Clean Water Act, and the National Environmental Policy Act, all of which are anticipated to generate desirable expansion opportunities for the market in North America during the course of the forecast period. Because of recent developments in miniaturization technology as well as the presence of important market players in the North American region, this region accounted for the largest revenue share in 2021. The rapid growth rate of the North American market can be attributed to the increasing expenditures made by governments in countries in the region for the development of healthcare sectors in those countries. Other factors that are contributing to the expansion of the North American market include increasing demand for point-of-care and at-home testing as a result of COVID-19 and an increasing need for medical diagnostics that are both more advanced and more cost-effective. Furthermore, increasing government funding for conducting research and development (R &D) of advanced biosensors for various application areas such as agriculture, biodefense, environmental monitoring, and other areas is expected to continue to support market revenue growth in countries such as the United States of America and Canada.The market for biosensors in APAC is likely to exhibit the highest growth rate from 2022 to 2030. The expansion of the market in APAC is being driven primarily by several factors, the most important of which are the region's vast population base and the rising prevalence of a variety of lifestyle-related disorders. Both in terms of the removal of items from the National Negative List and the addition of items to the National Encouraged List, the healthcare industry in China has been steadily opening up to the participation of foreign investors. This is true both in terms of the removal of items from the National Negative List and the addition of items to the National Encouraged List. The 2019 National Encouraged List was updated to include a number of newly added raw materials 2019. These raw materials will be used in the production of vaccines and medical facilities. This suggests that China is now encouraging investments across the healthcare industry and opening the door for opportunities for international companies to receive preferential regulations and tax rates. It is anticipated that such policies will generate a number of opportunities for the biosensors market in the APAC region.
During the period covered by the forecast, the market is anticipated to expand at a rate that is highest in both the Middle East and Africa. Some of the primary factors that are driving the market in the Middle East and Africa include the presence of significant unmet medical requirements for target diseases such as diabetes, cancer, and other infectious diseases; continuously improving healthcare expenditure in the region; and increasing patient awareness. A rise in demand for point-of-care, home healthcare, and other healthcare businesses that cater to the adult population, as well as measures taken by the government to reduce the length of patients' stays in hospitals by developing outpatient care models, are likely to fuel the expansion of the market over the course of the forecast period.
Top Companies to Dominate, Competition to Intensify During the Forecast Period
Because of the dramatic increase in demand for biosensors, manufacturers all over the world are intensifying their production processes while simultaneously enhancing them by incorporating more efficient market strategies. Leading companies in the market are mandating higher product quality in order to keep up with the surge in demand that is coming from a variety of applications for biosensors. The global market for biosensors is highly competitive, with only a few companies accounting for the majority of the market's revenue. Major players are implementing a variety of strategies, as well as engaging in mergers and acquisitions, strategic partnerships and contracts, and the development, testing, and introduction of more efficient biosensors. The market for biosensors is led by companies such as Abbott (based in the United States), Roche (based in Switzerland), Medtronic (based in Ireland), Bio-Rad Laboratories, Inc. (based in the United States), and DuPont (US).Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Biosensors market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Biosensors market and their expected impact during the forecast period.
Market Segmentation
Type
- Sensor Patch
- Embedded Device
Product
- Wearable Biosensors
- Non-wearable Biosensors
Technology
- Electrochemical Biosensors
- Optical Biosensors
- Piezoelectric Biosensors
- Thermal Biosensors
- Nanomechanical Biosensors
Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
End-user Outlook
- Home healthcare diagnostics
- PoC testing
- Food industry
- Research laboratories
- Security and bio-defense
Region Segment (2020 - 2030; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
- Pre Covid-19 situation
- Post Covid-19 situation
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Biosensors market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Biosensors market?
- Which is the largest regional market for Biosensors market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Biosensors market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Biosensors market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Biosensors Market
2.2. Global Biosensors Market, By Type, 2021 (US$ Million)
2.3. Global Biosensors Market, By By Product, 2021 (US$ Million)
2.4. Global Biosensors Market, By Technology, 2021 (US$ Million)
2.5. Global Biosensors Market, By Application, 2021 (US$ Million)
2.6. Global Biosensors Market, By End-user Outlook, 2021 (US$ Million)
2.7. Global Biosensors Market, By Geography, 2021 (US$ Million)
2.8. Impact of Covid 19
2.9. Attractive Investment Proposition by Geography, 2021
2.10. Competitive Analysis
2.10.1. Market Positioning of Key Biosensors Market Vendors
2.10.2. Strategies Adopted by Biosensors Market Vendors
2.10.3. Key Industry Strategies
2.10.4. Tier Analysis 2021 Versus 2030
2.11. Key Buying Criteria
2.12. Key Case Reports
2.13. Scenario Analysis
2.13.1. Optimistic estimates and analysis
2.13.2. Realistic estimates and analysis
2.13.3. Pessimistic estimates and analysis
2.14. Market Profiling
2.15. Sales and Marketing Plan
2.16. Top Market Conclusions
2.17. Strategic Recommendations
3. Biosensors Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Biosensors Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Biosensors Market: By Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Sensor Patch
4.3.2. Embedded Device
5. Biosensors Market: By By Product, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Wearable Biosensors
5.3.2. Non-wearable Biosensors
6. Biosensors Market: By Technology, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Electrochemical Biosensors
6.3.2. Optical Biosensors
6.3.3. Piezoelectric Biosensors
6.3.4. Thermal Biosensors
6.3.5. Nanomechanical Biosensors
7. Biosensors Market: By Application, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. Medical
7.3.1.1. Cholesterol
7.3.1.2. Blood glucose
7.3.1.3. Blood gas analyzer
7.3.1.4. Pregnancy testing
7.3.1.5. Drug discovery
7.3.1.6. Infectious disease
7.3.2. Food toxicity
7.3.3. Bioreactor
7.3.4. Agriculture
7.3.5. Environment
7.3.6. Others
8. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2021 Versus 2030
8.3. Market Segmentation
8.3.1. Home healthcare diagnostics
8.3.2. PoC testing
8.3.3. Food industry
8.3.4. Research laboratories
8.3.5. Security and bio-defense9. North America Biosensors Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Biosensors Market: By Type, 2020-2030, USD (Million)
9.3. Biosensors Market: By By Product, 2020-2030, USD (Million)
9.4. Biosensors Market: By Technology, 2020-2030, USD (Million)
9.5. Biosensors Market: By Application, 2020-2030, USD (Million)
9.6. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
9.7.Biosensors Market: By Region, 2020-2030, USD (Million)
9.7.1.North America
9.7.1.1. U.S.
9.7.1.1.1. Biosensors Market: By Type, 2020-2030, USD (Million)
9.7.1.1.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
9.7.1.1.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
9.7.1.1.4. Biosensors Market: By Application, 2020-2030, USD (Million)
9.7.1.1.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
9.7.1.2. Canada
9.7.1.2.1. Biosensors Market: By Type, 2020-2030, USD (Million)
9.7.1.2.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
9.7.1.2.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
9.7.1.2.4. Biosensors Market: By Application, 2020-2030, USD (Million)
9.7.1.2.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
9.7.1.3. Rest of North America
9.7.1.3.1. Biosensors Market: By Type, 2020-2030, USD (Million)
9.7.1.3.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
9.7.1.3.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
9.7.1.3.4. Biosensors Market: By Application, 2020-2030, USD (Million)
9.7.1.3.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10. UK and European Union Biosensors Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Biosensors Market: By Type, 2020-2030, USD (Million)
10.3. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.4. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.5. Biosensors Market: By Application, 2020-2030, USD (Million)
10.6. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.Biosensors Market: By Region, 2020-2030, USD (Million)
10.7.1.UK and European Union
10.7.1.1. UK
10.7.1.1.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.1.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.1.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.1.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.1.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.1.2. Germany
10.7.1.2.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.2.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.2.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.2.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.2.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.1.3. Spain
10.7.1.3.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.3.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.3.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.3.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.3.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.1.4. Italy
10.7.1.4.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.4.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.4.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.4.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.4.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.1.5. France
10.7.1.5.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.5.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.5.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.5.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.5.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
10.7.1.6. Rest of Europe
10.7.1.6.1. Biosensors Market: By Type, 2020-2030, USD (Million)
10.7.1.6.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
10.7.1.6.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
10.7.1.6.4. Biosensors Market: By Application, 2020-2030, USD (Million)
10.7.1.6.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11. Asia Pacific Biosensors Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Biosensors Market: By Type, 2020-2030, USD (Million)
11.3. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.4. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.5. Biosensors Market: By Application, 2020-2030, USD (Million)
11.6. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.Biosensors Market: By Region, 2020-2030, USD (Million)
11.7.1.Asia Pacific
11.7.1.1. China
11.7.1.1.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.1.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.1.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.1.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.1.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.1.2. Japan
11.7.1.2.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.2.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.2.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.2.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.2.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.1.3. India
11.7.1.3.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.3.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.3.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.3.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.3.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.1.4. Australia
11.7.1.4.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.4.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.4.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.4.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.4.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.1.5. South Korea
11.7.1.5.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.5.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.5.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.5.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.5.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
11.7.1.6. Rest of Asia Pacific
11.7.1.6.1. Biosensors Market: By Type, 2020-2030, USD (Million)
11.7.1.6.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
11.7.1.6.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
11.7.1.6.4. Biosensors Market: By Application, 2020-2030, USD (Million)
11.7.1.6.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
12. Latin America Biosensors Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Biosensors Market: By Type, 2020-2030, USD (Million)
12.3. Biosensors Market: By By Product, 2020-2030, USD (Million)
12.4. Biosensors Market: By Technology, 2020-2030, USD (Million)
12.5. Biosensors Market: By Application, 2020-2030, USD (Million)
12.6. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
12.7.Biosensors Market: By Region, 2020-2030, USD (Million)
12.7.1.Latin America
12.7.1.1. Brazil
12.7.1.1.1. Biosensors Market: By Type, 2020-2030, USD (Million)
12.7.1.1.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
12.7.1.1.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
12.7.1.1.4. Biosensors Market: By Application, 2020-2030, USD (Million)
12.7.1.1.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
12.7.1.2. Mexico
12.7.1.2.1. Biosensors Market: By Type, 2020-2030, USD (Million)
12.7.1.2.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
12.7.1.2.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
12.7.1.2.4. Biosensors Market: By Application, 2020-2030, USD (Million)
12.7.1.2.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
12.7.1.3. Rest of Latin America
12.7.1.3.1. Biosensors Market: By Type, 2020-2030, USD (Million)
12.7.1.3.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
12.7.1.3.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
12.7.1.3.4. Biosensors Market: By Application, 2020-2030, USD (Million)
12.7.1.3.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
13. Middle East and Africa Biosensors Market, 2020-2030, USD (Million)
13.1. Market Overview
13.2. Biosensors Market: By Type, 2020-2030, USD (Million)
13.3. Biosensors Market: By By Product, 2020-2030, USD (Million)
13.4. Biosensors Market: By Technology, 2020-2030, USD (Million)
13.5. Biosensors Market: By Application, 2020-2030, USD (Million)
13.6. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
13.7.Biosensors Market: By Region, 2020-2030, USD (Million)
13.7.1.Middle East and Africa
13.7.1.1. GCC
13.7.1.1.1. Biosensors Market: By Type, 2020-2030, USD (Million)
13.7.1.1.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
13.7.1.1.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
13.7.1.1.4. Biosensors Market: By Application, 2020-2030, USD (Million)
13.7.1.1.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
13.7.1.2. Africa
13.7.1.2.1. Biosensors Market: By Type, 2020-2030, USD (Million)
13.7.1.2.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
13.7.1.2.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
13.7.1.2.4. Biosensors Market: By Application, 2020-2030, USD (Million)
13.7.1.2.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
13.7.1.3. Rest of Middle East and Africa
13.7.1.3.1. Biosensors Market: By Type, 2020-2030, USD (Million)
13.7.1.3.2. Biosensors Market: By By Product, 2020-2030, USD (Million)
13.7.1.3.3. Biosensors Market: By Technology, 2020-2030, USD (Million)
13.7.1.3.4. Biosensors Market: By Application, 2020-2030, USD (Million)
13.7.1.3.5. Biosensors Market: By End-user Outlook, 2020-2030, USD (Million)
14. Company Profile
14.1. Abbott (U.S.)
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Roche (Switzerland)
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Medtronic (Ireland)
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Bio-Rad Laboratories (U.S.)
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. DuPont lead the biosensors market (US).
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
List of Figures
Figure 1 Global Biosensors Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Biosensors Market: Quality Assurance
Figure 5 Global Biosensors Market, By Type, 2021
Figure 6 Global Biosensors Market, By By Product, 2021
Figure 7 Global Biosensors Market, By Technology, 2021
Figure 8 Global Biosensors Market, By Application, 2021
Figure 9 Global Biosensors Market, By End-user Outlook, 2021
Figure 10 Global Biosensors Market, By Geography, 2021
Figure 11 Market Geographical Opportunity Matrix - Global Biosensors Market, 2021
Figure 12 Market Positioning of Key Biosensors Market Players, 2021
Figure 13 Global Biosensors Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 14 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 15 See Saw Analysis
Figure 16 PETEL Analysis
Figure 17 Key Buying Criteria: Current and Long-Term Perspective
Figure 18 Global Biosensors Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 19 Heptalysis Analysis: Global Biosensors Market
Figure 20 Five Whys Analysis
Figure 21 Global Biosensors Market, By Type, 2021 Vs 2030, %
Figure 22 Global Biosensors Market, By By Product, 2021 Vs 2030, %
Figure 23 Global Biosensors Market, By Technology, 2021 Vs 2030, %
Figure 24 Global Biosensors Market, By Application, 2021 Vs 2030, %
Figure 25 Global Biosensors Market, By End-user Outlook, 2021 Vs 2030, %
Figure 26 U.S. Biosensors Market (US$ Million), 2020 - 2030
Figure 27 Canada Biosensors Market (US$ Million), 2020 - 2030
Figure 28 Rest of North America Biosensors Market (US$ Million), 2020 - 2030
Figure 29 UK Biosensors Market (US$ Million), 2020 - 2030
Figure 30 Germany Biosensors Market (US$ Million), 2020 - 2030
Figure 31 Spain Biosensors Market (US$ Million), 2020 - 2030
Figure 32 Italy Biosensors Market (US$ Million), 2020 - 2030
Figure 33 France Biosensors Market (US$ Million), 2020 - 2030
Figure 34 Rest of Europe Biosensors Market (US$ Million), 2020 - 2030
Figure 35 China Biosensors Market (US$ Million), 2020 - 2030
Figure 36 Japan Biosensors Market (US$ Million), 2020 - 2030
Figure 37 India Biosensors Market (US$ Million), 2020 - 2030
Figure 38 Australia Biosensors Market (US$ Million), 2020 - 2030
Figure 39 South Korea Biosensors Market (US$ Million), 2020 - 2030
Figure 40 Rest of Asia Biosensors Market (US$ Million), 2020 - 2030
Figure 41 Brazil Biosensors Market (US$ Million), 2020 - 2030
Figure 42 Mexico Biosensors Market (US$ Million), 2020 - 2030
Figure 43 Rest of Latin America Biosensors Market (US$ Million), 2020 - 2030
Figure 44 GCC Biosensors Market (US$ Million), 2020 - 2030
Figure 45 Africa Biosensors Market (US$ Million), 2020 - 2030
Figure 46 Rest of Middle East and Africa Biosensors Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Biosensors Market By Type, 2020-2030, USD (Million)
Table 2 Global Biosensors Market By By Product, 2020-2030, USD (Million)
Table 3 Global Biosensors Market By Technology, 2020-2030, USD (Million)
Table 4 Global Biosensors Market By Application, 2020-2030, USD (Million)
Table 5 Global Biosensors Market By Medical, 2020-2030, USD (Million)
Table 6 Global Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 7 North America Biosensors Market By Type, 2020-2030, USD (Million)
Table 8 North America Biosensors Market By By Product, 2020-2030, USD (Million)
Table 9 North America Biosensors Market By Technology, 2020-2030, USD (Million)
Table 10 North America Biosensors Market By Application, 2020-2030, USD (Million)
Table 11 North America Biosensors Market By Medical, 2020-2030, USD (Million)
Table 12 North America Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 13 U.S. Biosensors Market By Type, 2020-2030, USD (Million)
Table 14 U.S. Biosensors Market By By Product, 2020-2030, USD (Million)
Table 15 U.S. Biosensors Market By Technology, 2020-2030, USD (Million)
Table 16 U.S. Biosensors Market By Application, 2020-2030, USD (Million)
Table 17 U.S. Biosensors Market By Medical, 2020-2030, USD (Million)
Table 18 U.S. Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 19 Canada Biosensors Market By Type, 2020-2030, USD (Million)
Table 20 Canada Biosensors Market By By Product, 2020-2030, USD (Million)
Table 21 Canada Biosensors Market By Technology, 2020-2030, USD (Million)
Table 22 Canada Biosensors Market By Application, 2020-2030, USD (Million)
Table 23 Canada Biosensors Market By Medical, 2020-2030, USD (Million)
Table 24 Canada Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 25 Rest of North America Biosensors Market By Type, 2020-2030, USD (Million)
Table 26 Rest of North America Biosensors Market By By Product, 2020-2030, USD (Million)
Table 27 Rest of North America Biosensors Market By Technology, 2020-2030, USD (Million)
Table 28 Rest of North America Biosensors Market By Application, 2020-2030, USD (Million)
Table 29 Rest of North America Biosensors Market By Medical, 2020-2030, USD (Million)
Table 30 Rest of North America Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 31 UK and European Union Biosensors Market By Type, 2020-2030, USD (Million)
Table 32 UK and European Union Biosensors Market By By Product, 2020-2030, USD (Million)
Table 33 UK and European Union Biosensors Market By Technology, 2020-2030, USD (Million)
Table 34 UK and European Union Biosensors Market By Application, 2020-2030, USD (Million)
Table 35 UK and European Union Biosensors Market By Medical, 2020-2030, USD (Million)
Table 36 UK and European Union Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 37 UK Biosensors Market By Type, 2020-2030, USD (Million)
Table 38 UK Biosensors Market By By Product, 2020-2030, USD (Million)
Table 39 UK Biosensors Market By Technology, 2020-2030, USD (Million)
Table 40 UK Biosensors Market By Application, 2020-2030, USD (Million)
Table 41 UK Biosensors Market By Medical, 2020-2030, USD (Million)
Table 42 UK Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 43 Germany Biosensors Market By Type, 2020-2030, USD (Million)
Table 44 Germany Biosensors Market By By Product, 2020-2030, USD (Million)
Table 45 Germany Biosensors Market By Technology, 2020-2030, USD (Million)
Table 46 Germany Biosensors Market By Application, 2020-2030, USD (Million)
Table 47 Germany Biosensors Market By Medical, 2020-2030, USD (Million)
Table 48 Germany Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 49 Spain Biosensors Market By Type, 2020-2030, USD (Million)
Table 50 Spain Biosensors Market By By Product, 2020-2030, USD (Million)
Table 51 Spain Biosensors Market By Technology, 2020-2030, USD (Million)
Table 52 Spain Biosensors Market By Application, 2020-2030, USD (Million)
Table 53 Spain Biosensors Market By Medical, 2020-2030, USD (Million)
Table 54 Spain Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 55 Italy Biosensors Market By Type, 2020-2030, USD (Million)
Table 56 Italy Biosensors Market By By Product, 2020-2030, USD (Million)
Table 57 Italy Biosensors Market By Technology, 2020-2030, USD (Million)
Table 58 Italy Biosensors Market By Application, 2020-2030, USD (Million)
Table 59 Italy Biosensors Market By Medical, 2020-2030, USD (Million)
Table 60 Italy Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 61 France Biosensors Market By Type, 2020-2030, USD (Million)
Table 62 France Biosensors Market By By Product, 2020-2030, USD (Million)
Table 63 France Biosensors Market By Technology, 2020-2030, USD (Million)
Table 64 France Biosensors Market By Application, 2020-2030, USD (Million)
Table 65 France Biosensors Market By Medical, 2020-2030, USD (Million)
Table 66 France Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 67 Rest of Europe Biosensors Market By Type, 2020-2030, USD (Million)
Table 68 Rest of Europe Biosensors Market By By Product, 2020-2030, USD (Million)
Table 69 Rest of Europe Biosensors Market By Technology, 2020-2030, USD (Million)
Table 70 Rest of Europe Biosensors Market By Application, 2020-2030, USD (Million)
Table 71 Rest of Europe Biosensors Market By Medical, 2020-2030, USD (Million)
Table 72 Rest of Europe Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 73 Asia Biosensors Market By Type, 2020-2030, USD (Million)
Table 74 Asia Biosensors Market By By Product, 2020-2030, USD (Million)
Table 75 Asia Biosensors Market By Technology, 2020-2030, USD (Million)
Table 76 Asia Biosensors Market By Application, 2020-2030, USD (Million)
Table 77 Asia Biosensors Market By Medical, 2020-2030, USD (Million)
Table 78 Asia Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 79 China Biosensors Market By Type, 2020-2030, USD (Million)
Table 80 China Biosensors Market By By Product, 2020-2030, USD (Million)
Table 81 China Biosensors Market By Technology, 2020-2030, USD (Million)
Table 82 China Biosensors Market By Application, 2020-2030, USD (Million)
Table 83 China Biosensors Market By Medical, 2020-2030, USD (Million)
Table 84 China Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 85 Japan Biosensors Market By Type, 2020-2030, USD (Million)
Table 86 Japan Biosensors Market By By Product, 2020-2030, USD (Million)
Table 87 Japan Biosensors Market By Technology, 2020-2030, USD (Million)
Table 88 Japan Biosensors Market By Application, 2020-2030, USD (Million)
Table 89 Japan Biosensors Market By Medical, 2020-2030, USD (Million)
Table 90 Japan Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 91 India Biosensors Market By Type, 2020-2030, USD (Million)
Table 92 India Biosensors Market By By Product, 2020-2030, USD (Million)
Table 93 India Biosensors Market By Technology, 2020-2030, USD (Million)
Table 94 India Biosensors Market By Application, 2020-2030, USD (Million)
Table 95 India Biosensors Market By Medical, 2020-2030, USD (Million)
Table 96 India Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 97 Australia Biosensors Market By Type, 2020-2030, USD (Million)
Table 98 Australia Biosensors Market By By Product, 2020-2030, USD (Million)
Table 99 Australia Biosensors Market By Technology, 2020-2030, USD (Million)
Table 100 Australia Biosensors Market By Application, 2020-2030, USD (Million)
Table 101 Australia Biosensors Market By Medical, 2020-2030, USD (Million)
Table 102 Australia Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 103 South Korea Biosensors Market By Type, 2020-2030, USD (Million)
Table 104 South Korea Biosensors Market By By Product, 2020-2030, USD (Million)
Table 105 South Korea Biosensors Market By Technology, 2020-2030, USD (Million)
Table 106 South Korea Biosensors Market By Application, 2020-2030, USD (Million)
Table 107 South Korea Biosensors Market By Medical, 2020-2030, USD (Million)
Table 108 South Korea Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 109 Latin America Biosensors Market By Type, 2020-2030, USD (Million)
Table 110 Latin America Biosensors Market By By Product, 2020-2030, USD (Million)
Table 111 Latin America Biosensors Market By Technology, 2020-2030, USD (Million)
Table 112 Latin America Biosensors Market By Application, 2020-2030, USD (Million)
Table 113 Latin America Biosensors Market By Medical, 2020-2030, USD (Million)
Table 114 Latin America Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 115 Brazil Biosensors Market By Type, 2020-2030, USD (Million)
Table 116 Brazil Biosensors Market By By Product, 2020-2030, USD (Million)
Table 117 Brazil Biosensors Market By Technology, 2020-2030, USD (Million)
Table 118 Brazil Biosensors Market By Application, 2020-2030, USD (Million)
Table 119 Brazil Biosensors Market By Medical, 2020-2030, USD (Million)
Table 120 Brazil Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 121 Mexico Biosensors Market By Type, 2020-2030, USD (Million)
Table 122 Mexico Biosensors Market By By Product, 2020-2030, USD (Million)
Table 123 Mexico Biosensors Market By Technology, 2020-2030, USD (Million)
Table 124 Mexico Biosensors Market By Application, 2020-2030, USD (Million)
Table 125 Mexico Biosensors Market By Medical, 2020-2030, USD (Million)
Table 126 Mexico Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 127 Rest of Latin America Biosensors Market By Type, 2020-2030, USD (Million)
Table 128 Rest of Latin America Biosensors Market By By Product, 2020-2030, USD (Million)
Table 129 Rest of Latin America Biosensors Market By Technology, 2020-2030, USD (Million)
Table 130 Rest of Latin America Biosensors Market By Application, 2020-2030, USD (Million)
Table 131 Rest of Latin America Biosensors Market By Medical, 2020-2030, USD (Million)
Table 132 Rest of Latin America Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 133 Middle East and Africa Biosensors Market By Type, 2020-2030, USD (Million)
Table 134 Middle East and Africa Biosensors Market By By Product, 2020-2030, USD (Million)
Table 135 Middle East and Africa Biosensors Market By Technology, 2020-2030, USD (Million)
Table 136 Middle East and Africa Biosensors Market By Application, 2020-2030, USD (Million)
Table 137 Middle East and Africa Biosensors Market By Medical, 2020-2030, USD (Million)
Table 138 Middle East and Africa Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 139 GCC Biosensors Market By Type, 2020-2030, USD (Million)
Table 140 GCC Biosensors Market By By Product, 2020-2030, USD (Million)
Table 141 GCC Biosensors Market By Technology, 2020-2030, USD (Million)
Table 142 GCC Biosensors Market By Application, 2020-2030, USD (Million)
Table 143 GCC Biosensors Market By Medical, 2020-2030, USD (Million)
Table 144 GCC Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 145 Africa Biosensors Market By Type, 2020-2030, USD (Million)
Table 146 Africa Biosensors Market By By Product, 2020-2030, USD (Million)
Table 147 Africa Biosensors Market By Technology, 2020-2030, USD (Million)
Table 148 Africa Biosensors Market By Application, 2020-2030, USD (Million)
Table 149 Africa Biosensors Market By Medical, 2020-2030, USD (Million)
Table 150 Africa Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Table 151 Rest of Middle East and Africa Biosensors Market By Type, 2020-2030, USD (Million)
Table 152 Rest of Middle East and Africa Biosensors Market By By Product, 2020-2030, USD (Million)
Table 153 Rest of Middle East and Africa Biosensors Market By Technology, 2020-2030, USD (Million)
Table 154 Rest of Middle East and Africa Biosensors Market By Application, 2020-2030, USD (Million)
Table 155 Rest of Middle East and Africa Biosensors Market By Medical, 2020-2030, USD (Million)
Table 156 Rest of Middle East and Africa Biosensors Market By End-user Outlook, 2020-2030, USD (Million)
Companies Mentioned
- Abbott (U.S.)
- Roche (Switzerland)
- Medtronic (Ireland)
- Bio-Rad Laboratories (U.S.)
- DuPont lead the biosensors market (US).
